Healthcare

Q & M Dental to acquire SG dental group with $34m profit guarantee

The acquisition will be funded through a mix of cash and new ordinary shares.

OUE Limited narrows loss to $279.1m in 2025

It was mainly due to the absence of fair value loss and lower finance expenses.

IHH Healthcare FY2025 net profit falls 21% to $682.67m

The decrease is due to unrealised currency translation losses from a stronger ringgit.

iX Biopharma secures $52.8m US contract for pain reliever trials

The funding will be allocated for the late-stage development of Wafermine. 

Hyphens Pharma profit dives 44% in 2025 despite record 40.7% gross margins

Net profit fell to $6.1m in 2025 as higher costs and inventory write-offs offset proprietary brand growth.

Singapore Paincare sinks to net loss on rising staff expenses

The group posted a $47,000 net loss in HY2026, reversing last year’s $781,000 profit.

iX Biopharma narrows losses in H1 FY 2026 despite 14% fall in revenue

Net loss narrowing to $2.1m, compared with a loss of $6.3m in 1H FY 2025.

Singapore Paincare expands operations and client base with TS Medical acquisition

The SGX-listed group acquired 51% of the company which operates Doctors for Life Medical.

Precision for Medicine widens APAC reach with new Singapore office

The new office will serve as its APAC hub for biomarker research.

SMART and NUS weaponize AI to give soft robots human-like reflexes

The system reduced tracking error by 44% to 55% under heavy disturbances.

NTU, Gu Sheng Tang push TCM research with $1.06m programme

Visiting experts from China will provide clinical mentorship for local practitioners.

$45b state surge triggers global VC influx to Singapore’s Biopolis

The 2% GDP spend on R&D served as a talent magnet for returning overseas scientists.

HSA clears cancer-detecting AI for routine hospital use

Intelligent Scopes Corp secures regulatory green light for its new bladder cancer software.